GLP1R and Hypoglycemia: In the same line with our findings, a previous SR of 112 RCTs reported a non-significant long-term increase of major adverse events related to GLP-1 RAs (38); however, a recent MA demonstrated mild gastrointestinal adverse events and hypoglycemia (39).